Giuseppe Corona (G Corona)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 19

Top Topics

Liquid Chromatography

Mass Spectrometry

Top Venues

Analytical methods : advancing methods and applications

Diagnostics (Basel, Switzerland)

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Gianmaria Miolo, Wally Marus, Angela Buonadonna, Lucia Da Ros, Lara Della Puppa, Giuseppe Corona
Null Mismatch Repair Proteins Expression Reveals the Temporal Molecular Events in Lynch Syndrome-Related Cancers. Diagnostics (Basel, Switzerland) 14 (9) (2024)
Giovanni Canil, Gianmaria Miolo, Mariapaola Simula, Maurizio Rupolo, Agostino Steffan, Giuseppe Corona
Quantitative assessment of daratumumab in serum via intact light chain measurement using liquid chromatography-high resolution mass spectrometry: a method suitable for therapeutic drug monitoring. Analytical methods : advancing methods and applications 16 (26) (2024)
Giovanni Canil, Gianmaria Miolo, Mariapaola Simula, Maurizio Rupolo, Agostino Steffan, Giuseppe Corona
Quantitative assessment of daratumumab in serum via intact light chain measurement using liquid chromatography-high resolution mass spectrometry: a method suitable for therapeutic drug monitoring. Analytical methods : advancing methods and applications (2024)
Gianmaria Miolo, Wally Marus, Angela Buonadonna, Lucia Da Ros, Lara Della Puppa, Giuseppe Corona
Null Mismatch Repair Proteins Expression Reveals the Temporal Molecular Events in Lynch Syndrome-Related Cancers. Diagnostics (Basel, Switzerland) 14 (9) (2024)
Angela Buonadonna, Simona Scalone, Davide Lombardi, Arianna Fumagalli, Alessandra Guglielmi, Chiara Lestuzzi, Jerry Polesel, Vincenzo Canzonieri, Stefano Lamon, Petros Giovanis, Sara Gagno, Giuseppe Corona, Maurizio Mascarin, Claudio Belluco, Antonino De Paoli, Gianpiero Fasola, Fabio Puglisi, Gianmaria Miolo
Prospective, Multicenter Phase II Trial of Non-Pegylated Liposomal Doxorubicin Combined with Ifosfamide in First-Line Treatment of Advanced/Metastatic Soft Tissue Sarcomas. Cancers 15 (20) (2023)
Davide Adriano Santeufemia, Giuseppe Palmieri, Gianmaria Miolo, Maria Colombino, Maria Grazia Doro, Laura Frogheri, Panagiotis Paliogiannis, Giampiero Capobianco, Massimo Madonia, Antonio Cossu, Giovanni Lo Re, Giuseppe Corona
Current Trends in Mucosal Melanomas: An Overview. Cancers 15 (5) (2023)
Davide Adriano Santeufemia, Giuseppe Palmieri, Gianmaria Miolo, Maria Colombino, Maria Grazia Doro, Laura Frogheri, Panagiotis Paliogiannis, Giampiero Capobianco, Massimo Madonia, Antonio Cossu, Giovanni Lo Re, Giuseppe Corona
Current Trends in Mucosal Melanomas: An Overview. Cancers 15 (5) (2023)
Gianmaria Miolo, Angela Buonadonna, Simona Scalone, Davide Lombardi, Lara Della Puppa, Agostino Steffan, Giuseppe Corona
Metabolic Clues to Bile Acid Patterns and Prolonged Survival in Patients with Metastatic Soft-Tissue Sarcoma Treated with Trabectedin. Metabolites 13 (10) (2023)
Asia Saorin, Emanuela Di Gregorio, Angela Buonadonna, Gianmaria Miolo, Giuseppe Corona
The Riddle of Cetuximab-Related Skin Toxicity: 1 H-NMR Sebum Analysis Revealed Dynamic Lipid Alterations Associated with Skin Toxicity Development in Metastatic Colorectal Cancer Patients. Cancers 14 (21) (2022)
Emanuela Di Gregorio, Gianmaria Miolo, Asia Saorin, Elena Muraro, Michela Cangemi, Alberto Revelant, Emilio Minatel, Marco Trovò, Agostino Steffan, Giuseppe Corona
Radical Hemithoracic Radiotherapy Induces Systemic Metabolomics Changes That Are Associated with the Clinical Outcome of Malignant Pleural Mesothelioma Patients. Cancers 13 (3) (2021)
Giuseppe Corona, Emanuela Di Gregorio, Alessia Vignoli, Elena Muraro, Agostino Steffan, Gianmaria Miolo
1H-NMR Plasma Lipoproteins Profile Analysis Reveals Lipid Metabolism Alterations in HER2-Positive Breast Cancer Patients. Cancers 13 (22) (2021)
Emanuela Di Gregorio, Gianmaria Miolo, Asia Saorin, Agostino Steffan, Giuseppe Corona
From Metabolism to Genetics and Vice Versa: The Rising Role of Oncometabolites in Cancer Development and Therapy. International journal of molecular sciences 22 (11) (2021)
Asia Saorin, Emanuela Di Gregorio, Gianmaria Miolo, Agostino Steffan, Giuseppe Corona
Emerging Role of Metabolomics in Ovarian Cancer Diagnosis. Metabolites 10 (10) (2020)
Gianmaria Miolo, Emanuela Di Gregorio, Asia Saorin, Davide Lombardi, Simona Scalone, Angela Buonadonna, Agostino Steffan, Giuseppe Corona
Integration of Serum Metabolomics into Clinical Assessment to Improve Outcome Prediction of Metastatic Soft Tissue Sarcoma Patients Treated with Trabectedin. Cancers 12 (7) (2020)
Muhammad Altaf, Naike Casagrande, Elena Mariotto, Nadeem Baig, Abdel-Nasser Kawde, Giuseppe Corona, Roberto Larcher, Cinzia Borghese, Claudia Pavan, Adam A Seliman, Donatella Aldinucci, Anvarhusein A Isab
Potent In Vitro and In Vivo Anticancer Activity of New Bipyridine and Bipyrimidine Gold (III) Dithiocarbamate Derivatives. Cancers 11 (4) (2019)
Stefano Palazzolo, Mohamad Hadla, Concetta Russo Spena, Isabella Caligiuri, Rossella Rotondo, Muhammad Adeel, Vinit Kumar, Giuseppe Corona, Vincenzo Canzonieri, Giuseppe Toffoli, Flavio Rizzolio
An Effective Multi-Stage Liposomal DNA Origami Nanosystem for In Vivo Cancer Therapy. Cancers 11 (12) (2019)
Giuseppe Corona, Milena Gusella, Anna Gaspardo, Gianmaria Miolo, Laura Bertolaso, Elisa Pezzolo, Felice Pasini, Agostino Steffan, Donatella Caruso
Rapid LC-MS/MS method for quantification of vinorelbine and 4-O-deacetylvinorelbine in human whole blood suitable to monitoring oral metronomic anticancer therapy. Biomedical chromatography : BMC (2018)
S D'Aronco, M Dall'Armi, Sara Crotti, E Calandra, P Traldi, Valerio Di Marco, A Buonadonna, Giuseppe Corona, L Giodini, Elena Marangon, B Posocco, Giuseppe Toffoli, Marco Agostini
Field-assisted paper spray mass spectrometry for therapeutic drug monitoring: 1. the case of imatinib in plasma. Journal of mass spectrometry : JMS 52 (5) (2018)
Giuseppe Corona, Renato Cannizzaro, Gianmaria Miolo, Laura Caggiari, Mariangela De Zorzi, Ombretta Repetto, Agostino Steffan, Valli De Re
Use of Metabolomics as a Complementary Omic Approach to Implement Risk Criteria for First-Degree Relatives of Gastric Cancer Patients. International journal of molecular sciences 19 (3) (2018)